Synthetic cannabinoids (SCs) are a class of new psychoactive substances (NPSs) that
exhibit high affinity binding to the cannabinoid CB1 and CB2 receptors and display a …

Detection of illicit drugs in the environmental samples has been challenged as the
consumption increases globally. Current review examines the recent developments and …

Synthetic cannabinoid receptor agonists (SCRAs) are an evolving class of new psychoactive
substances (NPS) with structurally diverse compounds emerging each year. Due to the rapid …

Drug misuse in prisons contributes to increased disruption and violence and negatively
impacts prisoner safety, rehabilitation, and recovery. Synthetic cannabinoid receptor …

Early warning systems detect new psychoactive substances (NPS), while dedicated
monitoring programs and routine drug and toxicology testing identify fluctuations in …

A new class of synthetic cannabinoids has emerged as new psychoactive substances
(NPS). Similar in structure to JWH‐022, these substances contain alkene modifications to …

Abstract Cannabinoid receptors type 1 (CB 1) and type 2 (CB 2) are promising targets for a
number of diseases, including obesity, neuropathic pain, and multiple sclerosis, among …

The present work is the last of a three‐part study investigating a panel of 30 systematically
designed synthetic cannabinoid receptor agonists (SCRAs) including features such as the 4 …

Abstract Novel Psychoactive Substances (NPS) represent an alternative to established illicit
drugs. They are traded via the internet and exhibit small alterations in their chemical …

Recreational consumption of synthetic cannabinoid receptor agonists (SCRAs) is a growing
crisis in public health in many parts of the world. AMB-FUBINACA is a member of this class …